Invention Grant
- Patent Title: Frigostable composition for iontophoretic transdermal delivery of a triptan compound
-
Application No.: US16772775Application Date: 2018-12-13
-
Publication No.: US11744806B2Publication Date: 2023-09-05
- Inventor: Michael Linn , Christoph Schmitz , Hanshermann Franke
- Applicant: LTS Lohmann Therapie-Systeme AG
- Applicant Address: DE Andernach
- Assignee: LTS Lohmann Theraapie-Systeme AG
- Current Assignee: LTS Lohmann Theraapie-Systeme AG
- Current Assignee Address: DE Andernach
- Agency: ProPat, LLC
- Agent Cathy Moore; Vinisha Joshi
- Priority: EP 208940 2017.12.20
- International Application: PCT/EP2018/084699 2018.12.13
- International Announcement: WO2019/121293A 2019.06.27
- Date entered country: 2020-06-13
- Main IPC: A61K9/70
- IPC: A61K9/70 ; A61K9/00 ; A61K31/4045 ; A61K47/12 ; A61K47/34

Abstract:
The present invention relates to frigostable compositions suitable for iontophoretic transdermal delivery of a triptan compound. The inventive compositions include a salt of a triptan compound, preferably sumatriptan succinate, a polyamine, a dicarboxylic acid, and water or an aqueous solvent mixture, with the composition being free of monocarboxylic acids. The invention further relates to the use of the composition as an integral component of an iontophoretic patch, preferably as an anodic reservoir of the patch.
Public/Granted literature
- US20200323787A1 FRIGOSTABLE COMPOSITION FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF A TRIPTAN COMPOUND Public/Granted day:2020-10-15
Information query